Loading
Eric Haura is a lung cancer physician-scientist who maps drug-target signalling with proteomics.
Eric B. Haura is Associate Center Director for Clinical Science and Director of the Lung Cancer Center of Excellence at Moffitt Cancer Center. He is a lung cancer physician-scientist known for mapping drug-target signalling with proteomics, using phosphoproteomics and protein-interaction mapping to understand why kinase inhibitors work and then fail. His selected paper reports proteomic and phosphoproteomic analyses of EGFR-mutant lung cancer. He now directs Moffitt's lung cancer centre and continues to study signalling networks in non-small-cell lung cancer.
| Title | Journal | Year |
|---|---|---|
| Proteomic and phosphoproteomic analyses of EGFR-mutant lung cancer | Molecular Cancer Therapeutics | 2016 |
Shares Proteomics & phosphoproteomics, Non-small-cell lung cancer.
Shares Proteomics & phosphoproteomics, Non-small-cell lung cancer.
Shares Proteomics & phosphoproteomics, Non-small-cell lung cancer.